Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Hypoglycemia

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Hypoglycemia in 2 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Hypoglycemia: A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Soto-Montenegro, ML1
Vaquero, JJ1
Arango, C1
Ricaurte, G1
GarcĂ­a-Barreno, P1
Desco, M1
Montgomery, H1
Myerson, S1

Other Studies

2 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Hypoglycemia

ArticleYear
Effects of MDMA on blood glucose levels and brain glucose metabolism.
    European journal of nuclear medicine and molecular imaging, 2007, Volume: 34, Issue:6

    Topics: Adrenergic Uptake Inhibitors; Amygdala; Animals; Auditory Cortex; Blood Glucose; Brain; Cerebellum;

2007
3,4-methylenedioxymethamphetamine (MDMA, or "ecstasy") and associated hypoglycemia.
    The American journal of emergency medicine, 1997, Volume: 15, Issue:2

    Topics: Acute Disease; Adult; Dantrolene; Female; Fever; Hallucinogens; Humans; Hypoglycemia; Muscle Relaxan

1997